News

19/1/2018

Ema and big pharma: conflict of interests or not?

Can the European Medicines Agency (EMA) be truly independent, if it also is in close contact with the pharmaceutical industry? Read more

Blog

17/1/2018

‘Recruiting health workers from Africa? Just plain unacceptable.’

Last week, Wemos’ global health advocate Linda Mans shared her knowledge of the migration and mobility of health workers with global health students during two workshops at the University of Groningen. Read more

News

12/1/2018

No ban on BPA in food contact materials

There will be no European ban on the endocrine-disrupting chemical Bisphenol A (BPA). The European Parliament has voted that BPA will remain in food contact materials. Wemos regrets that European citizens will therefore remain exposed to this harmful substance. Read more

News

4/1/2018

The long arm of the pharmaceutical industry

How does the pharmaceutical industry influence the European Medicines Agency? Can the organization independently carry out its work? Read more

Blog

2/1/2018

Why future African doctors in training should become lobbyists

The lack of health professionals worldwide is estimated around 18 million in 2030, especially in low- and middle-income countries. Read more

News

12/12/2017

Why EMA can do more for clinical trial subjects

Malpractices in clinical trials are still common. In October, three Members of the European Parliament requested the European Medicines Agency to address these issues. The agency’s reply to the letter still leaves Wemos concerned. Read more

News

6/12/2017

More influence on health care for businesses

Businesses and private investors are increasingly involved in public health issues worldwide. Civil society organizations and experts share their concerns about this in Barcelona this week. Wemos is one of these organizations. Read more

Blog

28/11/2017

Health systems advocacy from inside the story

‘A good health system finds people where they are, it is easily accessible when and how people need it,’ stated Amanda Banda during the first Global Health Café Read more

Blog

22/11/2017

Medicijnen in de Tweede Kamer

Vandaag vindt in de Tweede Kamer een Algemeen Overleg geneesmiddelenbeleid plaats. Vooruitlopend op het overleg organiseerde Wemos vorige week in de Tweede Kamer een bijeenkomst over het belang van voorwaarden verbinden aan publieke investeringen in medicijnen. Read more